Naxalgan (Pregabalin)

Pregabalin, the active ingredient in Naxalgan, is a gabapentinoid presented as a tablet for oral use. It is prescribed for neuropathic pain, seizure control, fibromyalgia and generalized anxiety disorder. The product originates from the European Union and complies with international quality standards.

GNH USA supplies Naxalgan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pregabalin acts on the nervous system to alleviate pain, control seizures, and reduce anxiety. It is used in several well‑established clinical situations: - Diabetic peripheral neuropathy: reduces pain associated with nerve damage in diabetes. - Postherpetic neuralgia: relieves lingering nerve pain after shingles. - Partial seizures: provides adjunctive therapy to improve seizure control. - Fibromyalgia: lessens widespread musculoskeletal pain and fatigue. - Generalized anxiety disorder: decreases excessive worry and tension.

Pregabalin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision - Dry mouth

Serious or Rare Side Effects: - Angioedema - Severe hypersensitivity reactions - Suicidal thoughts or behavior - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hematologic abnormalities (e.g., thrombocytopenia) - Respiratory depression in high‑risk patients

Before initiating therapy, consider the following safety measures: - Renal impairment: adjust dose based on renal function. - Elderly patients: monitor for increased sedation and falls. - History of substance misuse: use with caution due to abuse potential. - Suicidality risk: observe for mood changes and emergent suicidal thoughts. - Pregnancy and lactation: discuss potential risks with the prescriber. - Store at room temperature: keep in the original container, protect from moisture.

Pregabalin can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Opioids: additive central nervous system depression. - Alcohol: heightened sedation and dizziness. - ACE inhibitors: increased risk of angioedema. - CNS depressants (e.g., benzodiazepines): profound sedation.

Moderate Interactions (Monitor Closely): - Diuretics: may raise pregabalin serum concentrations. - Antihypertensives: potential additive hypotensive effect. - Anticholinergic agents: may exacerbate dry mouth.